Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

vicagrel

Phase 3Small molecule

JJiangsu vcare pharmaceutical technology co., LTD

1

Indications

8

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)Recruiting

Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)Phase 3

Recruiting

Timeline

Expected Milestones

Q4 2026

Phase 3Recruiting

Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)

NCT06577519

Clinical

Trials by Indication[1]

Clopidogrel2 trials

Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal Metabolizers

Completed·JJiangsu vcare pharmaceutical technology co., LTD·Phase 1·NCT07067775·18 enrolled

PK/PD Study of Vicagrel and Clopidogrel in Healthy Subjects With Different CYP2C19 Metabolizers

Completed·JJiangsu vcare pharmaceutical technology co., LTD·Phase 1·NCT05162053·128 enrolled

Adult Subject1 trial

Pharmacokinetics and Pharmacodynamics of Vicagrel in Healthy Adult Subjects of Different CYP2C19

Completed·JJiangsu vcare pharmaceutical technology co., LTD·Phase 1·NCT03942458·50 enrolled

Antiplatelet Therapy1 trial

The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel

Completed·JJiangsu vcare pharmaceutical technology co., LTD·Phase 2·NCT03599284·279 enrolled

Clinical Trial1 trial

A Clinical Trial to Evaluate the Effect of Food on PK and PD of Vicagrel Capsules in Healthy Adult Subjects

Completed·JJiangsu vcare pharmaceutical technology co., LTD·Phase 1·NCT04919551·24 enrolled

ESS1 trial

Assessment of the Effect of Omeprazole on Vicagrel in Healthy Subjects

Unknown status·JJiangsu vcare pharmaceutical technology co., LTD·Phase 1·NCT05651074·20 enrolled

2 more indications

Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)1 trial

Efficacy and Safety of Vicagrel in Patients With With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI): a Multi-center, Randomized, Double-blind, Double-dummy , Parallel-controlled, Phase III Trial

Recruiting·JJiangsu vcare pharmaceutical technology co., LTD·Phase 3·NCT06577519·1,000 enrolled

Unspecified1 trial

The Mass Balance and Biotransformation of [14C] Vicagrel in Healthy Man

Completed·JJiangsu vcare pharmaceutical technology co., LTD·Phase 1·NCT04143750·6 enrolled

Sources

References

[1]
ClinicalTrials.gov — 8 trial records for vicagrel. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — vicagrel compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for vicagrel. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Jiangsu vcare pharmaceutical technology co., LTD company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: JJiangsu vcare pharmaceutical technology co., LTD

Related News